Sandra Wymann

470 total citations
20 papers, 355 citations indexed

About

Sandra Wymann is a scholar working on Immunology, Hematology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Sandra Wymann has authored 20 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 12 papers in Hematology and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Sandra Wymann's work include Platelet Disorders and Treatments (11 papers), Complement system in diseases (8 papers) and Blood groups and transfusion (8 papers). Sandra Wymann is often cited by papers focused on Platelet Disorders and Treatments (11 papers), Complement system in diseases (8 papers) and Blood groups and transfusion (8 papers). Sandra Wymann collaborates with scholars based in Switzerland, Australia and United States. Sandra Wymann's co-authors include Sylvia Miescher, Adrian W. Zuercher, Fabian Käsermann, A.F. Hofmann, Alexander Schaub, Katharina Willimann, Eleonora Widmer, Reinhard Bolli, M. Spycher and Srini V. Kaveri and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Scientific Reports.

In The Last Decade

Sandra Wymann

18 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sandra Wymann Switzerland	11	216	138	132	82	40	20	355
Jean-François Séïté France	6	268 1.2×	83 0.6×	128 1.0×	86 1.0×	24 0.6×	7	395
Emmanuelle Bonnin France	7	257 1.2×	172 1.2×	151 1.1×	85 1.0×	39 1.0×	10	477
J Mikulska Poland	7	190 0.9×	64 0.5×	243 1.8×	194 2.4×	23 0.6×	13	413
Satoshi Shiokawa Japan	10	227 1.1×	65 0.5×	100 0.8×	38 0.5×	34 0.8×	24	375
C. M. Hurd United Kingdom	12	189 0.9×	158 1.1×	88 0.7×	60 0.7×	70 1.8×	18	432
Qile Song China	5	307 1.4×	38 0.3×	183 1.4×	67 0.8×	110 2.8×	11	441
M Svenson Denmark	9	236 1.1×	51 0.4×	118 0.9×	48 0.6×	39 1.0×	9	398
G. Lemm United States	9	173 0.8×	194 1.4×	49 0.4×	58 0.7×	68 1.7×	20	402
Rozenn Le Corre France	11	174 0.8×	28 0.2×	79 0.6×	80 1.0×	26 0.7×	21	304
M P Font France	10	204 0.9×	43 0.3×	72 0.5×	87 1.1×	120 3.0×	12	388

Countries citing papers authored by Sandra Wymann

Since Specialization

Citations

This map shows the geographic impact of Sandra Wymann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Wymann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Wymann more than expected).

Fields of papers citing papers by Sandra Wymann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Wymann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Wymann. The network helps show where Sandra Wymann may publish in the future.

Co-authorship network of co-authors of Sandra Wymann

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Wymann. A scholar is included among the top collaborators of Sandra Wymann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Wymann. Sandra Wymann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Biondo, Mark, et al.. (2025). CSL040 ameliorates primary graft dysfunction in pre-clinical models of lung transplantation. Immunobiology. 230(4). 152991–152991.

Wymann, Sandra, Tanja Ruthsatz, Anjan K. Bongoni, et al.. (2025). Pre-clinical characterization of CSL040, a soluble complement receptor 1 (CR1) fragment. Immunobiology. 230(4). 152992–152992.

Ruthsatz, Tanja, Sandra Wymann, Elena Velkoska, et al.. (2024). Preclinical safety and efficacy of the recombinant CR1 drug product CSL040 in rats and cynomolgus monkeys. Toxicology and Applied Pharmacology. 495. 117191–117191. 1 indexed citations

Wymann, Sandra, et al.. (2024). Mechanistic insights into complement pathway inhibition by CR1 domain duplication. Journal of Biological Chemistry. 300(7). 107451–107451. 2 indexed citations

Beckmann, Katrin, Thomas Gentinetta, Daniel Couto, et al.. (2024). Haptoglobin Attenuates Cerebrospinal Fluid Hemoglobin-Induced Neurological Deterioration in Sheep. Translational Stroke Research. 16(3). 728–732. 5 indexed citations

Mansour, Mariam, et al.. (2023). The Molecular Mechanisms of Complement Receptor 1—It Is Complicated. Biomolecules. 13(10). 1522–1522. 8 indexed citations

Hardy, Matthew P., Tony Rowe, & Sandra Wymann. (2022). Soluble Complement Receptor 1 Therapeutics. 6(4). 1–17. 6 indexed citations

Bongoni, Anjan K., Ingela B. Vikstrom, Jennifer L. McRae, et al.. (2021). A potent truncated form of human soluble CR1 is protective in a mouse model of renal ischemia–reperfusion injury. Scientific Reports. 11(1). 21873–21873. 11 indexed citations

Galeotti, Caroline, Emmanuel Stephen‐Victor, Anupama Karnam, et al.. (2018). Intravenous immunoglobulin induces IL-4 in human basophils by signaling through surface-bound IgE. Journal of Allergy and Clinical Immunology. 144(2). 524–535.e8. 38 indexed citations

10.

Das, Mrinmoy, Emmanuel Stephen‐Victor, Meenu Sharma, et al.. (2017). Monomeric Immunoglobulin A from Plasma Inhibits Human Th17 Responses In Vitro Independent of FcαRI and DC-SIGN. Frontiers in Immunology. 8. 275–275. 22 indexed citations

11.

Mielke, Orell, Stefano Fontana, Vesselina Goranova‐Marinova, et al.. (2017). Hemolysis related to intravenous immunoglobulins is dependent on the presence of anti‐blood group A and B antibodies and individual susceptibility. Transfusion. 57(11). 2629–2638. 12 indexed citations

12.

Gerber, Simon, et al.. (2016). Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment. BioDrugs. 30(5). 441–451. 17 indexed citations

13.

Willimann, Katharina, Sandra Wymann, Eleonora Widmer, et al.. (2015). Isoagglutinin reduction by a dedicated immunoaffinity chromatography step in the manufacturing process of human immunoglobulin products. Transfusion. 55(S2). S117–21. 20 indexed citations

14.

Willimann, Katharina, et al.. (2015). Donor screening reduces the isoagglutinin titer in immunoglobulin products. Transfusion. 55(S2). S95–7. 9 indexed citations

15.

Willimann, Katharina, et al.. (2014). Isoagglutinin Reduction in Human Immunoglobulin Products by Donor Screening. PubMed. 4(1-2). 15–26. 26 indexed citations

16.

Käsermann, Fabian, et al.. (2012). Analysis and Functional Consequences of Increased Fab-Sialylation of Intravenous Immunoglobulin (IVIG) after Lectin Fractionation. PLoS ONE. 7(6). e37243–e37243. 98 indexed citations

17.

Wymann, Sandra, Adrian W. Zuercher, Alexander Schaub, et al.. (2011). Monomeric and Dimeric IgG Fractions Show Differential Reactivity Against Pathogen‐Derived Antigens. Scandinavian Journal of Immunology. 74(1). 31–41. 5 indexed citations

18.

Schaub, Alexander, Stephan von Gunten, Monique Vogel, et al.. (2011). Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes. Allergy. 66(8). 1030–1037. 37 indexed citations

19.

Wymann, Sandra, Alexander Schaub, Michael Baumann, et al.. (2008). Monomerization of dimeric IgG of intravenous immunoglobulin (IVIg) increases the antibody reactivity against intracellular antigens. Molecular Immunology. 45(9). 2621–2628. 22 indexed citations

20.

Schaub, Alexander, Sandra Wymann, Manfred Heller, et al.. (2007). Self‐Reactivity in the Dimeric Intravenous Immunoglobulin Fraction. Annals of the New York Academy of Sciences. 1110(1). 681–693. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact